AR026300A1 - NEW COMPOUNDS FOR THE TREATMENT OF VASCULAR COMPLICATIONS RELATED TO DIABETES AND AGING, THE PROCESS FOR PREPARATION AND THERAPEUTIC USES. - Google Patents
NEW COMPOUNDS FOR THE TREATMENT OF VASCULAR COMPLICATIONS RELATED TO DIABETES AND AGING, THE PROCESS FOR PREPARATION AND THERAPEUTIC USES.Info
- Publication number
- AR026300A1 AR026300A1 ARP000105723A ARP000105723A AR026300A1 AR 026300 A1 AR026300 A1 AR 026300A1 AR P000105723 A ARP000105723 A AR P000105723A AR P000105723 A ARP000105723 A AR P000105723A AR 026300 A1 AR026300 A1 AR 026300A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- different
- heteroaryl
- aryl
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Describe compuestos nuevos de la serie piridinio utiles para el tratamietno de las complicaciones vasculares por diabetes y relacionadas con elenvejecimiento, incluyento a las enfermedades del rion en nervios, aterosclerosis, retinopatías, trastornos dermatologicos y decoloracion de los dientes, laruptura el AGE pre formado, de la formula general 1, o sus sales faramcéuticamente aceptables, donde R1 es -R4-R5 o -N(R7)N(R7)R9; R4 se selecciona del grupoformado por -N(R7)R6O-, -N(R7)R6N(R7)-, OR6O , y -OR6N(R7)-, donde R6 es alquilo; R5 se selecciona del grupo formado por alquilo, arilo incluyendo heteroarilo,-COR7, SO2 R7; -C(S)NHR7, -C(NH)MHR7, -COR10, -C(O)NHR7 y -N(R7)N=CR7R10 donde R7 se selecciona del grupo formado por H, alquilo y arilo incluyendo heteroarilosi R7 fuera diferente para R1 y R3 en el mismo compuesto; R2 se selecciona del grupo formado por H, alquilo ya rilo incluyendo heteroarilo si R7 fueradiferente para R1 y R3 en el mismo compuesto; R2 se selecciona del grupo form ado por F, CL, Br, I, OR7, NO2, alquilo,a rilo incluyendo heteroarilo, formilo,acilo, C(O)NR7R10, C(I)OR7, NR7R10, N=C(R7)(R10), SR7, SO2NH2, SO2 alquilo y SO2 arilo, y m es 0, 1 o 2; R3 se selecciona del grupo formado por R7, OR7, N(R7)(R10), N=C(R7 )(R10), N(R7)N(R7)(R10), N(R7) N=C(R7)(R10) y CH(R7)C(O)R8 donde R8 se selecciona del grupo formado por R7, OR7 y NR7R10; R9 se selecciona delgrupo formado por hidrogeno, alquilo,a rilo incluyendo heteroarilo, C(O)R10, -SO2R10, -C(S)NHR10, -C(NH)NH(R 10) y -C(O)NHR10, R10 se selecciona del grupoformado por H, alquilo o arilo incluyendo heteroarilo y en cada caso, es opcionalmente diferente del sustituyente R10, si R10 fuera diferente de R1 y R3 en elmismo compuesto; X se selecciona del grupo for mado por un ion de haluro, acetato, perclorato, sulfonato, oxalato, citrato, tosilato, amleato, mesilato,carbonato, sulfito, hidrogeno fosforico, fosfonato, fosfato, BF4- y PF6; con la condicion de que, (i)cuando dos grupos alquilo están presentes en el mismocarobno o nitrogeno, están enlazados opcionalmente para formar una estructura cíclica y (ii)el nitrogeno del anillo heteroarilo de R10, cuando está presente,It describes new compounds of the pyridinium series useful for the treatment of vascular complications due to diabetes and related to aging, including diseases of the kidney in nerves, atherosclerosis, retinopathies, dermatological disorders and discoloration of teeth, larupture of pre-formed AGE, of the general formula 1, or its pharmaceutically acceptable salts, wherein R1 is -R4-R5 or -N (R7) N (R7) R9; R4 is selected from the group formed by -N (R7) R6O-, -N (R7) R6N (R7) -, OR6O, and -OR6N (R7) -, where R6 is alkyl; R5 is selected from the group consisting of alkyl, aryl including heteroaryl, -COR7, SO2 R7; -C (S) NHR7, -C (NH) MHR7, -COR10, -C (O) NHR7 and -N (R7) N = CR7R10 where R7 is selected from the group consisting of H, alkyl and aryl including heteroarylsi R7 is different for R1 and R3 in the same compound; R2 is selected from the group consisting of H, alkyl and ryl including heteroaryl if R7 is different for R1 and R3 in the same compound; R2 is selected from the group consisting of F, CL, Br, I, OR7, NO2, alkyl, a ryl including heteroaryl, formyl, acyl, C (O) NR7R10, C (I) OR7, NR7R10, N = C (R7 ) (R10), SR7, SO2NH2, SO2 alkyl and SO2 aryl, and m is 0, 1 or 2; R3 is selected from the group consisting of R7, OR7, N (R7) (R10), N = C (R7) (R10), N (R7) N (R7) (R10), N (R7) N = C (R7 ) (R10) and CH (R7) C (O) R8 where R8 is selected from the group consisting of R7, OR7 and NR7R10; R9 is selected from the group consisting of hydrogen, alkyl, a ryl including heteroaryl, C (O) R10, -SO2R10, -C (S) NHR10, -C (NH) NH (R 10) and -C (O) NHR10, R10 it is selected from the group formed by H, alkyl or aryl including heteroaryl and in each case, is optionally different from the substituent R10, if R10 is different from R1 and R3 in the same compound; X is selected from the group formed by a halide, acetate, perchlorate, sulfonate, oxalate, citrate, tosylate, aminate, mesylate, carbonate, sulphite, phosphoric hydrogen, phosphonate, phosphate, BF4- and PF6 ion; with the proviso that, (i) when two alkyl groups are present in the same carbon or nitrogen, they are optionally linked to form a cyclic structure and (ii) the nitrogen of the heteroaryl ring of R10, when present,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1197496P | 1996-02-20 | 1996-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026300A1 true AR026300A1 (en) | 2003-02-05 |
Family
ID=21752774
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970100681A AR005929A1 (en) | 1996-02-20 | 1997-02-20 | METHOD FOR THE PREPARATION OF DIFENIL ISOXAZOLIL SULFONAMIDAS AND INTERMEDIATE COMPOUNDS FOR APPLICATION IN SUCH METHODS. |
ARP000105723A AR026300A1 (en) | 1996-02-20 | 2000-10-30 | NEW COMPOUNDS FOR THE TREATMENT OF VASCULAR COMPLICATIONS RELATED TO DIABETES AND AGING, THE PROCESS FOR PREPARATION AND THERAPEUTIC USES. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970100681A AR005929A1 (en) | 1996-02-20 | 1997-02-20 | METHOD FOR THE PREPARATION OF DIFENIL ISOXAZOLIL SULFONAMIDAS AND INTERMEDIATE COMPOUNDS FOR APPLICATION IN SUCH METHODS. |
Country Status (4)
Country | Link |
---|---|
AR (2) | AR005929A1 (en) |
RU (1) | RU2209815C2 (en) |
TW (1) | TW402597B (en) |
ZA (1) | ZA971289B (en) |
-
1997
- 1997-01-28 TW TW086100922A patent/TW402597B/en not_active IP Right Cessation
- 1997-02-14 ZA ZA971289A patent/ZA971289B/en unknown
- 1997-02-19 RU RU98117735/04A patent/RU2209815C2/en not_active IP Right Cessation
- 1997-02-20 AR ARP970100681A patent/AR005929A1/en unknown
-
2000
- 2000-10-30 AR ARP000105723A patent/AR026300A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
RU2209815C2 (en) | 2003-08-10 |
TW402597B (en) | 2000-08-21 |
AR005929A1 (en) | 1999-07-21 |
ZA971289B (en) | 1998-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2043617T3 (en) | A PROCEDURE FOR PREPARING BENZAMIDE DERIVATIVES. | |
AP1687A (en) | Therapeutic biaryl derivatives. | |
DK602589A (en) | quinazolinone | |
IT1055123B (en) | PREPARATION OF COMPLEXES CONSTITUTED BY METAL SALTS OF IMI DAZOLO I SOSITUITO | |
FR2669336B1 (en) | NOVEL OXAZOLO PYRIDINES DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
FR2370731A1 (en) | NEW DERIVATIVES OF PIPERIDINE POLYSUBSTITUES, THEIR METHODS OF PREPARATION AND THEIR PHARMACEUTICAL APPLICATION | |
DK1031563T3 (en) | sulphonyl derivatives | |
GB1477114A (en) | 1,4-dihydropyridinecarboxylic acid aralkyl esters processes for their preparation and their use as medicaments | |
MX9504287A (en) | Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents. | |
ES2043830T3 (en) | A METHOD FOR PREPARING A COMPOUND OF BIS- (METHYLENE DIOXY) BIPHENYL. | |
CO5021223A1 (en) | CALCILITICAL CALCILITICAL COMPOUNDS | |
ES2057159T3 (en) | STEREO-SPECIFIC PROCEDURE FOR THE PREPARATION OF FURO (3,4-C) PYRIDINE ENANTIOMERS, COMPOUNDS SO OBTAINED AND THERAPEUTIC COMPOSITIONS BASED ON THESE COMPOUNDS. | |
AR026300A1 (en) | NEW COMPOUNDS FOR THE TREATMENT OF VASCULAR COMPLICATIONS RELATED TO DIABETES AND AGING, THE PROCESS FOR PREPARATION AND THERAPEUTIC USES. | |
PT88062A (en) | PROCESS FOR THE PREPARATION OF TETRA-HYDRO-ISOQUINOLINE DERIVATIVES | |
EP0219852A3 (en) | Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same | |
ES472290A1 (en) | Diorthosubstituted benzene derivatives, especially for use in a method of therapy, processes for their preparation, and pharmaceutical compositions containing them. | |
ES2131549T3 (en) | 16-LINK MACROLID DERIVATIVES AND THEIR PREPARATION PROCEDURE. | |
AR031564A1 (en) | PIRIDINUM COMPOUNDS, THE PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS, A PROCESS FOR THE PREPARATION OF PARENTERAL FORMULATION, AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
FR2413358A1 (en) | NEW 2-AMINOMETHYLPHENOL DERIVATIVES, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY AGENTS, AND THEIR PREPARATION PROCESS | |
BR7605977A (en) | PROCESS FOR THE PREPARATION OF N- (1,2,4-TRIAZIN-5-ON-4-IL) DERIVATIVES GLYCIN, AS WELL AS COMPOSITIONS HERBECIFIED THEREOF | |
AR036346A1 (en) | BENZO [B] PIRANO [3,2H] -ACRIDIN-7-ONA COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2378518A1 (en) | NEW MEDICINES BASED ON TETRAHYDRODIBENZOPYRANE DERIVATIVES | |
HUP9802645A2 (en) | New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them | |
GB1389505A (en) | 3,4-dihydropyridones their production and their medicinal use | |
ES2062146T3 (en) | PROCEDURE FOR PREPARING NEW PLATINUM COMPLEXES AND ANTI-TUMOR AGENTS THAT CONTAIN THEM AS AN ACTIVE INGREDIENT. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FG | Grant, registration |